m6A-sequencing revealed the m6A hypermethylation of several key innate immune mediators, including OAS1, OAS2, OAS3, and ADAR1 in human islets and EndoC-βH1 cells at T1D onset. This evidence concerns the gene ADAR and type 1 diabetes mellitus.